Pages that link to "Q44936401"
Jump to navigation
Jump to search
The following pages link to Parkinson's disease is associated with altered expression of CaV1 channels and calcium-binding proteins. (Q44936401):
Displaying 50 items.
- Reduced Risk of Parkinson's Disease in Users of Calcium Channel Blockers: A Meta-Analysis (Q26783271) (← links)
- Glutamate excitotoxicity in neurons triggers mitochondrial and endoplasmic reticulum accumulation of Parkin, and, in the presence of N-acetyl cysteine, mitophagy (Q28387592) (← links)
- Hippocampal α-synuclein and interneurons in Parkinson's disease: Data from human and mouse models (Q31060511) (← links)
- Altered Ca2 homeostasis induces Calpain-Cathepsin axis activation in sporadic Creutzfeldt-Jakob disease (Q33612558) (← links)
- Calcineurin determines toxic versus beneficial responses to α-synuclein (Q34120215) (← links)
- Immunocytochemical Localization of Calbindin D28K, Calretinin, and Parvalbumin in Bat Superior Colliculus (Q34184458) (← links)
- Insights from cerebellar transcriptomic analysis into the pathogenesis of ataxia (Q35747030) (← links)
- Inhibition of Calpain Activation Protects MPTP-Induced Nigral and Spinal Cord Neurodegeneration, Reduces Inflammation, and Improves Gait Dynamics in Mice (Q36021445) (← links)
- Localization of Nitric Oxide Synthase-containing Neurons in the Bat Visual Cortex and Co-localization with Calcium-binding Proteins (Q36042669) (← links)
- Lower Affinity of Isradipine for L-Type Ca2 Channels during Substantia Nigra Dopamine Neuron-Like Activity: Implications for Neuroprotection in Parkinson's Disease. (Q36395464) (← links)
- Cooperative and acute inhibition by multiple C-terminal motifs of L-type Ca2 channels (Q37613903) (← links)
- The pathomechanisms underlying Parkinson's disease (Q38182660) (← links)
- Calcium signaling in Parkinson's disease. (Q38208179) (← links)
- The ongoing pursuit of neuroprotective therapies in Parkinson disease (Q38275171) (← links)
- Targeting voltage-gated calcium channels in neurological and psychiatric diseases (Q38626606) (← links)
- Isradipine attenuates MPTP-induced dopamine neuron degeneration by inhibiting up-regulation of L-type calcium channels and iron accumulation in the substantia nigra of mice (Q38703042) (← links)
- Parkinson's Disease and Neurodegeneration: GABA-Collapse Hypothesis (Q38845589) (← links)
- Topographical Distribution of Morphological Changes in a Partial Model of Parkinson's Disease--Effects of Nanoencapsulated Neurotrophic Factors Administration. (Q38867773) (← links)
- Molecular changes in the postmortem parkinsonian brain (Q38887346) (← links)
- Selective neuronal vulnerability in Parkinson disease (Q39095738) (← links)
- The role of Ca2 signaling in Parkinson's disease (Q39281423) (← links)
- Calbindin content and differential vulnerability of midbrain efferent dopaminergic neurons in macaques (Q41674970) (← links)
- Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons (Q42705179) (← links)
- α-Synuclein staging in the amygdala of a Parkinson's disease model: cell types involved. (Q44281222) (← links)
- Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments (Q45873810) (← links)
- Neuromelanin in Parkinson's Disease: from Fenton Reaction to Calcium Signaling (Q46311037) (← links)
- Parkinson's Disease Is Not Simply a Prion Disorder (Q47314960) (← links)
- Calcium dynamics control K-ATP channel-mediated bursting in substantia nigra dopamine neurons: a combined experimental and modeling study (Q47661489) (← links)
- Calcium, mitochondrial dysfunction and slowing the progression of Parkinson's disease (Q48165108) (← links)
- Altered Expression of Brain Proteinase-Activated Receptor-2, Trypsin-2 and Serpin Proteinase Inhibitors in Parkinson's Disease. (Q48172426) (← links)
- Portraying the Effect of Calcium-Binding Proteins on Cytosolic Calcium Concentration Distribution Fractionally in Nerve Cells. (Q48418523) (← links)
- Calcium Channel Antagonists as Disease-Modifying Therapy for Parkinson's Disease: Therapeutic Rationale and Current Status. (Q48435757) (← links)
- Calcium CaV1 channel subtype mRNA expression in Parkinson's disease examined by in situ hybridization. (Q48574096) (← links)
- iPSC-derived neurons from GBA1-associated Parkinson's disease patients show autophagic defects and impaired calcium homeostasis (Q48729780) (← links)
- Sodium and Potassium Relating to Parkinson's Disease and Traumatic Brain Injury (Q48919718) (← links)
- Alpha-synuclein aggregates activate calcium pump SERCA leading to calcium dysregulation. (Q51732455) (← links)
- How close are we to revealing the etiology of Parkinson's disease? (Q53371751) (← links)
- Low-expressed testis-specific calcium-binding protein CBP86-IV (CABYR) is observed in idiopathic asthenozoospermia. (Q54172830) (← links)
- Evidence for Sprouting of Dopamine and Serotonin Axons in the Pallidum of Parkinsonian Monkeys. (Q55002495) (← links)
- T-type Calcium Channels Determine the Vulnerability of Dopaminergic Neurons to Mitochondrial Stress in Familial Parkinson Disease (Q57818216) (← links)
- Reduced Cytosolic Calcium as an Early Decisive Cellular State in Parkinson's Disease and Synucleinopathies (Q59128094) (← links)
- Neurite Collapse and Altered ER Ca Control in Human Parkinson Disease Patient iPSC-Derived Neurons with LRRK2 G2019S Mutation (Q61454783) (← links)
- Calcium, Dopamine and Neuronal Calcium Sensor 1: Their Contribution to Parkinson's Disease (Q64061152) (← links)
- Gene co-expression network analysis for identifying genetic markers in Parkinson's disease - a three-way comparative approach (Q64868728) (← links)
- Redox Mechanisms in Neurodegeneration: From Disease Outcomes to Therapeutic Opportunities (Q88316783) (← links)
- Multiplex protein-specific microscopy with ultraviolet surface excitation (Q89496757) (← links)
- Aza-CGP37157-lipoic hybrids designed as novel Nrf2-inducers and antioxidants exert neuroprotection against oxidative stress and show neuroinflammation inhibitory properties (Q91142563) (← links)
- GABAergic changes in the thalamocortical circuit in Parkinson's disease (Q91266263) (← links)
- Single-Channel Resolution of the Interaction between C-Terminal CaV1.3 Isoforms and Calmodulin (Q91655529) (← links)
- Alterations of Calcium Channels in a Mouse Model of Huntington's Disease and Neuroprotection by Blockage of CaV1 Channels (Q92876042) (← links)